64 related articles for article (PubMed ID: 19013745)
1. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
[TBL] [Abstract][Full Text] [Related]
2. Oncological and Reproductive Outcomes after Fertility-Sparing Surgery in Patients with Advanced-Stage Serous Borderline Ovarian Tumor: A Single-Center Retrospective Study.
Cang W; Liang C; Wang D; Xue X; Cao D; Yang J; Pan L; Wu M; Yang J; Xiang Y
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762767
[TBL] [Abstract][Full Text] [Related]
3. Fertility-Preserving Surgery of Borderline Serous Ovarian Tumors: A Case Report.
Mohapatra I; Samantaray SR; Harshini N
Cureus; 2022 Apr; 14(4):e24128. PubMed ID: 35573497
[TBL] [Abstract][Full Text] [Related]
4. Oncologic and reproductive outcomes of borderline ovarian tumors in Indian population.
Kumari S; Kumar S; Bhatla N; Mathur S; Thulkar S; Kumar L
Gynecol Oncol Rep; 2021 May; 36():100756. PubMed ID: 33889704
[TBL] [Abstract][Full Text] [Related]
5. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
Wang P; Fang L
World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
[TBL] [Abstract][Full Text] [Related]
6. Borderline ovarian tumours: management in the era of fertility-sparing surgery.
Maramai M; Barra F; Menada MV; Stigliani S; Moioli M; Costantini S; Ferrero S
Ecancermedicalscience; 2020; 14():1031. PubMed ID: 32419843
[TBL] [Abstract][Full Text] [Related]
7. Oncologic and obstetric outcomes of conservative surgery for borderline ovarian tumors in women of reproductive age.
Lee SY; Choi MC; Kwon BR; Jung SG; Park H; Joo WD; Lee C; Lee JH; Lee JM
Obstet Gynecol Sci; 2017 May; 60(3):289-295. PubMed ID: 28534015
[TBL] [Abstract][Full Text] [Related]
8. A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma.
Hannibal CG; Vang R; Junge J; Frederiksen K; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Jan; 144(1):174-180. PubMed ID: 27836204
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis on the impact of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors with invasive implants.
Vasconcelos I; Olschewski J; Braicu I; Sehouli J
Oncologist; 2015 Feb; 20(2):151-8. PubMed ID: 25601963
[TBL] [Abstract][Full Text] [Related]
10. A nationwide study of serous "borderline" ovarian tumors in Denmark 1978-2002: centralized pathology review and overall survival compared with the general population.
Hannibal CG; Vang R; Junge J; Frederiksen K; Kjaerbye-Thygesen A; Andersen KK; Tabor A; Kurman RJ; Kjaer SK
Gynecol Oncol; 2014 Aug; 134(2):267-73. PubMed ID: 24924123
[TBL] [Abstract][Full Text] [Related]
11. Advanced stage micropapillary serous borderline ovarian tumor in a postmenopausal woman: a case report.
Güngör T; Kaba M; Başer E; Yalçın H; Bayramoğlu H; Beşli M
J Turk Ger Gynecol Assoc; 2012; 13(3):208-11. PubMed ID: 24592040
[TBL] [Abstract][Full Text] [Related]
12. Histologic distribution of borderline ovarian tumors worldwide: a systematic review.
Song T; Lee YY; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
J Gynecol Oncol; 2013 Jan; 24(1):44-51. PubMed ID: 23346313
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis, treatment, and follow-up of borderline ovarian tumors.
Fischerova D; Zikan M; Dundr P; Cibula D
Oncologist; 2012; 17(12):1515-33. PubMed ID: 23024155
[TBL] [Abstract][Full Text] [Related]
14. Behaviour of ovarian tumors of low malignant potential treated with conservative surgery.
De Iaco P; Ferrero A; Rosati F; Melpignano M; Biglia N; Rolla M; De Aloysio D; Sismondi P
Eur J Surg Oncol; 2009 Jun; 35(6):643-8. PubMed ID: 19013745
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors.
Yinon Y; Beiner ME; Gotlieb WH; Korach Y; Perri T; Ben-Baruch G
Fertil Steril; 2007 Aug; 88(2):479-84. PubMed ID: 17408624
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
Suh-Burgmann E
Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
[TBL] [Abstract][Full Text] [Related]
17. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
18. Conservative surgery for borderline ovarian tumors: a review.
Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
[TBL] [Abstract][Full Text] [Related]
19. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
